Give to Melanoma Research and Treatment
“Philanthropy is a game-changer for innovating new models of care at CPMC.”
Funding New Treatments for Melanoma
In an inspired moment of philanthropic partnership, Thomas and Mary Ellen Benninger, Elyse Eng, David and Martha Irmer, Ted and Wendy Hoffman, and William R. Payden, as well as his estate and his sister Joan Payden, all gave gifts to create the Chair in Melanoma Research and Treatment at CPMC.
Held by Mohammed Kashani-Sabet, M.D., the chair’s funding will help him and his team in their quest to create effective new treatments for melanoma.
Dr. Kashani says, "Philanthropic investments allow us to accomplish truly extraordinary things that we couldn’t otherwise do. Take cancer treatment, for example. These funds make a significant impact on the care patients receive at CPMC, including underwriting innovative research that elevates all of our cancer programs. And when you’re known for being on the leading edge, you can recruit the best medical talent around, which makes the research that much stronger and the clinical care patients receive even better. That’s how you build exceptional cancer programs, and philanthropy is a game-changer for innovating new models of care at CPMC.
"San Francisco is smaller than other well-known U.S. cities and has fewer hospitals, so we play an important role in the life of the city. Our Comprehensive Cancer Program is nationally accredited and offers exceptional service with multidisciplinary teams of specialists consulting on virtually every case. Plus, we have the advantage of working closely with dozens of remarkably talented scientists at CPMC Research Institute. It’s very rare to find all of that combined into one community hospital.”
Watch a video of Dr. Kashani describing innovative melanoma research and new therapies available at Sutter Health's CPMC.
CPMC patients with stage 4 melanoma have a 5-year survival rate that is nearly double that of the national average.
More than 2,500 patients are treated for cancer every year at CPMC.